Literature DB >> 26274999

Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells.

Xiaochun Jiang1, Yukui Yan2, Minghua Hu1, Xiande Chen1, Yaxian Wang2, Yi Dai1, Degang Wu1, Yongsheng Wang3, Zhixiang Zhuang4, Hongping Xia1.   

Abstract

OBJECT Increased levels of H19 long noncoding RNA (lncRNA) have been observed in many cancers, suggesting that overexpression of H19 may be important in the development of carcinogenesis. However, the role of H19 in human glioblastoma is still unclear. The object of this study was to examine the level of H19 in glioblastoma samples and investigate the role of H19 in glioblastoma carcinogenesis. METHODS Glioblastoma and nontumor brain tissue specimens were obtained from tissue obtained during tumor resection in 30 patients with glioblastoma. The level of H19 lncRNA was detected by real-time quantitative reverse transcription polymerase chain reaction. The role of H19 in invasion, angiogenesis, and stemness of glioblastoma cells was then investigated using commercially produced cell lines (U87 and U373). The effects of H19 overexpression on glioblastoma cell invasion and angiogenesis were detected by in vitro Matrigel invasion and endothelial tube formation assay. The effects of H19 on glioblastoma cell stemness and tumorigenicity were investigated by neurosphere formation and an in vivo murine xenograft model. RESULTS The authors found that H19 is significantly overexpressed in glioblastoma tissues, and the level of expression was associated with patient survival. In the subsequent investigations, the authors found that overexpression of H19 promotes glioblastoma cell invasion and angiogenesis in vitro. Interestingly, H19 was also significantly overexpressed in CD133(+) glioblastoma cells, and overexpression of H19 was associated with increased neurosphere formation of glioblastoma cells. Finally, stable overexpression of H19 was associated with increased tumor growth in the murine xenograft model. CONCLUSIONS The results of this study suggest that increased expression of H19 lncRNA promotes invasion, angiogenesis, stemness, and tumorigenicity of glioblastoma cells. Taken together, these findings indicate that H19 plays an important role in tumorigenicity and stemness of glioblastoma and thus could be a therapeutic target for treatment of glioblastoma in the future.

Entities:  

Keywords:  FBS = fetal bovine serum; H19; HCC = hepatocellular carcinoma; HUVEC = human umbilical vein endothelial cell; RT-qPCR = real-time quantitative reverse transcription polymerase chain reaction; SD = standard deviation; angiogenesis; glioblastoma; invasion; lncRNA = long noncoding RNA; long noncoding RNA; mouse; ncRNA = noncoding RNA; oncology; stemness

Mesh:

Substances:

Year:  2015        PMID: 26274999     DOI: 10.3171/2014.12.JNS1426

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  66 in total

Review 1.  The emerging role of lncRNAs in the regulation of cancer stem cells.

Authors:  Rosario Castro-Oropeza; Jorge Melendez-Zajgla; Vilma Maldonado; Karla Vazquez-Santillan
Journal:  Cell Oncol (Dordr)       Date:  2018-09-14       Impact factor: 6.730

2.  miR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675.

Authors:  Peiheng He; Ziji Zhang; Guangxin Huang; Hua Wang; Dongliang Xu; Weiming Liao; Yan Kang
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

3.  Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis.

Authors:  Xiaowen Liu; Renrong Lv; Linfeng Zhang; Guangqi Xu; Jianhai Bi; Feng Gao; Jian Zhang; Feng Xue; Fagang Wang; Yiliang Wu; Cong Fu; Qiang Wang; Ran Huo
Journal:  Tumour Biol       Date:  2016-10-05

Review 4.  Long non-coding RNAs: emerging players in osteosarcoma.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-12-30

5.  The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development.

Authors:  Shuang Liu; Ramkrishna Mitra; Ming-Ming Zhao; Wenhong Fan; Christine M Eischen; Feng Yin; Zhongming Zhao
Journal:  Mol Cancer Ther       Date:  2016-10-26       Impact factor: 6.261

Review 6.  The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer.

Authors:  Clément Lecerf; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Cell Mol Life Sci       Date:  2019-07-23       Impact factor: 9.261

7.  The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells.

Authors:  Reza Vazifehmand; Dhuha Saeed Ali; Zulkefley Othman; De-Ming Chau; Johnson Stanslas; Mehdi Shafa; Zamberi Sekawi
Journal:  J Neurovirol       Date:  2022-08-11       Impact factor: 3.739

8.  Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.

Authors:  H Cai; X Liu; J Zheng; Y Xue; J Ma; Z Li; Z Xi; Z Li; M Bao; Y Liu
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

9.  Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.

Authors:  Jinquan Cai; Jinwei Zhang; Pengfei Wu; Weitong Yang; Qile Ye; Qun Chen; Chuanlu Jiang
Journal:  J Neurooncol       Date:  2018-07-24       Impact factor: 4.130

10.  MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma.

Authors:  Alessia Lo Dico; Viviana Costa; Cristina Martelli; Cecilia Diceglie; Francesca Rajata; Aroldo Rizzo; Carmine Mancone; Marco Tripodi; Luisa Ottobrini; Riccardo Alessandro; Alice Conigliaro
Journal:  Theranostics       Date:  2016-05-08       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.